ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,464,358 | -5.5% | 6,976,238 | +0.2% | 0.00% | 0.0% |
| Q2 2023 | $11,075,037 | +121.7% | 6,965,432 | +0.0% | 0.00% | 0.0% |
| Q1 2023 | $4,996,434 | +20.8% | 6,964,642 | -2.4% | 0.00% | – |
| Q4 2022 | $4,134,762 | -39.3% | 7,135,052 | -0.5% | 0.00% | -100.0% |
| Q3 2022 | $6,811,000 | -23.0% | 7,169,565 | -2.7% | 0.00% | 0.0% |
| Q2 2022 | $8,843,000 | +1785.5% | 7,369,481 | +1962.4% | 0.00% | – |
| Q1 2022 | $469,000 | -45.8% | 357,318 | -27.3% | 0.00% | – |
| Q4 2021 | $865,000 | -72.6% | 491,491 | -66.2% | 0.00% | – |
| Q3 2021 | $3,158,000 | -5.8% | 1,455,644 | +51.9% | 0.00% | – |
| Q2 2021 | $3,353,000 | -52.9% | 958,190 | +32.7% | 0.00% | -100.0% |
| Q1 2021 | $7,119,000 | +0.5% | 721,930 | +10.4% | 0.00% | 0.0% |
| Q4 2020 | $7,087,000 | +1202.8% | 653,884 | +1135.6% | 0.00% | – |
| Q3 2020 | $544,000 | -56.1% | 52,919 | -10.8% | 0.00% | – |
| Q2 2020 | $1,238,000 | +790.6% | 59,315 | +316.6% | 0.00% | – |
| Q1 2020 | $139,000 | -86.0% | 14,237 | -83.5% | 0.00% | – |
| Q4 2019 | $992,000 | -39.3% | 86,136 | -71.3% | 0.00% | – |
| Q3 2019 | $1,634,000 | +689.4% | 299,635 | +1617.7% | 0.00% | – |
| Q2 2019 | $207,000 | +24.7% | 17,444 | -45.0% | 0.00% | – |
| Q1 2019 | $166,000 | -70.7% | 31,734 | -82.3% | 0.00% | – |
| Q4 2018 | $566,000 | -58.4% | 179,497 | -20.2% | 0.00% | – |
| Q3 2018 | $1,361,000 | +84.4% | 224,867 | +61.5% | 0.00% | – |
| Q2 2018 | $738,000 | -67.2% | 139,211 | -64.1% | 0.00% | -100.0% |
| Q1 2018 | $2,251,000 | +11.0% | 388,124 | -33.0% | 0.00% | 0.0% |
| Q4 2017 | $2,028,000 | +33700.0% | 579,181 | +34009.6% | 0.00% | – |
| Q3 2017 | $6,000 | +100.0% | 1,698 | +51.6% | 0.00% | – |
| Q2 2017 | $3,000 | -98.1% | 1,120 | -98.1% | 0.00% | – |
| Q1 2017 | $162,000 | -59.5% | 59,832 | -56.6% | 0.00% | – |
| Q4 2016 | $400,000 | +640.7% | 137,750 | +933.5% | 0.00% | – |
| Q3 2016 | $54,000 | +8.0% | 13,329 | -16.2% | 0.00% | – |
| Q2 2016 | $50,000 | – | 15,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |